Market By Source Type, Methodology, Applications, Products & Services, End-users And Geography | Forecast 2019-2027
The intraoperative neuromonitoring market in North America is projected to expand with 5.10% of CAGR in the estimated duration between 2019 and 2027.
The countries assessed in the report on North America’s intraoperative neuromonitoring market are:
• The United States
• Canada
In 2018, the North American region contributed the largest share to the global intraoperative neuromonitoring market. The market in North America is estimated to continue leading the global market throughout the forecasting period. The primary reason for this is the rise in prevalence of chronic disorders, high rate of adoption of IONM, presence of state-of-the-art healthcare infrastructure, reimbursement framework in favor of IONM, and increased awareness among patients about IONM.
Report scope can be customized per your requirements. Request For Customization
Several medium & large-scale product manufacturers and service providers, as well as start-ups, are focused on offering neuromonitoring services to hospitals & surgeons; for orthopedic, neurosurgery and spine & vascular surgeries. Companies like Natus Medical, NuVasive, Medtronic and SpecialityCare are engaged in providing advanced intraoperative neuromonitoring devices to hospitals and service providers. The service providers cater to the areas of orthopedic surgery, vascular surgery, neurosurgery and intracranial surgery. Investments are being made for research & development in order to produce more accurate and efficient technologically advanced intraoperative neuromonitoring devices.
The United States contributes the major revenue to the North America intraoperative neuromonitoring market. The rise in prevalence of chronic disorders and the increasing number of surgeries has increased the adoption of IONM devices. Besides, the growing per capita income and increased healthcare spending have raised the demand for these devices, thus propelling the growth of the market. The US market for intraoperative neuromonitoring is also fueled by the growth in infrastructure capabilities aimed at providing insourced IONM services.
Checkpoint Surgical is a US-based medical device company that develops neurodevices for surgeons to help in locating & identifying nerves and evaluating nerve & muscle excitability in surgical procedures. Checkpoint Stimulator & Locator, Checkpoint Head & Neck and Cova Ortho-Nerve are some of the products offered by the company. Checkpoint Surgical sells its products with the help of a distributor network in the United States. The company was founded in 2009 and is headquartered in Cleveland, Ohio.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1.
NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET - SUMMARY
2.
INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1.
OUTSOURCED INTRAOPERATIVE NEUROMONITORING IS EXPECTED TO DOMINATE THE
MARKET
2.2.2.
EP IS A WIDELY USED METHODOLOGY OF INTRAOPERATIVE NEUROMONITORING
2.2.3.
SPINAL SURGERY IS THE LARGEST APPLICATION OF INTRAOPERATIVE
NEUROMONITORING
2.2.4.
SERVICES SEGMENT IS GROWING AT A RAPID RATE
2.2.5.
AMBULATORY SURGICAL CENTERS (ASCs) ARE RAPIDLY ADOPTING INTRAOPERATIVE
NEUROMONITORING
2.3. PORTER’S FIVE FORCE ANALYSIS
2.3.1.
THREAT OF NEW ENTRANTS
2.3.2.
THREAT OF SUBSTITUTE
2.3.3.
BARGAINING POWER OF SUPPLIERS
2.3.4.
BARGAINING POWER OF BUYERS
2.3.5.
INTENSITY OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. MARKET DRIVERS
2.6.1.
INCREASING NEUROLOGICAL AND OTHER DISORDERS LEADING TO SURGERIES
2.6.2.
TECHNOLOGICAL ADVANCEMENT
2.6.3.
REDUCTION OF COMPLICATION DURING COMPLEX SURGERIES USING INTRAOPERATIVE
NEUROMONITORING
2.6.4.
INCREASING AGING POPULATION
2.7. MARKET RESTRAINTS
2.7.1.
HIGH COST OF IONM DEVICES AND SERVICES
2.7.2.
LACK OF SKILLED OPERATORS
2.8. MARKET OPPORTUNITIES
2.8.1.
RISE IN THE DEMAND FOR THE USE OF INTRAOPERATIVE NEUROMONITORING FOR MINIMALLY
INVASIVE SURGERIES
2.8.2.
DEVELOPMENT OF REMOTE INTRAOPERATIVE NEUROMONITORING
2.8.3.
EMERGENCE OF PORTABLE INTRAOPERATIVE NEUROMONITORING
2.9. MARKET CHALLENGES
2.9.1.
AVAILABILITY OF LESS COSTLY SUBSTITUTES
3.
INTRAOPERATIVE NEUROMONITORING MARKET OUTLOOK - BY SOURCE TYPE
3.1. INSOURCED INTRAOPERATIVE NEUROMONITORING
3.2. OUTSOURCED INTRAOPERATIVE NEUROMONITORING
4.
INTRAOPERATIVE NEUROMONITORING MARKET OUTLOOK - BY METHODOLOGY
4.1. EEG MONITORING
4.2. EMG MONITORING
4.3. EP MONITORING
4.3.1.
SEP MONITORING
4.3.2.
TCMEP MONITORING
4.3.3.
BAEP MONITORING
4.3.4.
VEP MONITORING
5.
INTRAOPERATIVE NEUROMONITORING MARKET OUTLOOK - BY APPLICATIONS
5.1. SPINAL SURGERY
5.2. ENT SURGERY
5.3. NEUROSURGERY
5.4. VASCULAR SURGERY
5.5. ORTHOPEDIC SURGERY
5.6. OTHER SURGERIES
6.
INTRAOPERATIVE NEUROMONITORING MARKET OUTLOOK - BY PRODUCTS &
SERVICES
6.1. SYSTEMS
6.2. ACCESSORIES
6.3. SERVICES
7.
INTRAOPERATIVE NEUROMONITORING MARKET OUTLOOK - BY END-USERS
7.1. HOSPITALS
7.2. AMBULATORY SURGICAL CENTERS (ASCs)
8.
INTRAOPERATIVE NEUROMONITORING MARKET - NORTH AMERICA
8.1. UNITED STATES
8.2. CANADA
9.
COMPETITIVE LANDSCAPE
9.1. ACCURATE NEUROMONITORING
9.2. INOMED MEDIZINTECHNIK GMBH
9.3. CADWELL
9.4. MOBERG RESEARCH, INC. (DAYONE MEDICAL LLC)
9.5. CNS NEUROMONITORING
9.6. COMPUTATIONAL DIAGNOSTICS
9.7. EMOTIV
9.8. INTRANERVE
9.9. MEDSURANT MONITORING
9.10.
MEDTRONIC
9.11.
NATUS MEDICAL
9.12.
SPECIALTYCARE
9.13.
NEUROMONITORING TECHNOLOGIES
9.14.
NEUROSENTINEL
9.15.
NIHON KOHDEN
9.16.
NUVASIVE
9.17.
CHECKPOINT SURGICAL
9.18.
ZYNEX
9.19.
ORIMTEC
10. RESEARCH METHODOLOGY & SCOPE
10.1.
RESEARCH SCOPE & DELIVERABLES
10.1.1.
OBJECTIVES OF STUDY
10.1.2.
SCOPE OF STUDY
10.2.
SOURCES OF DATA
10.2.1.
PRIMARY DATA SOURCES
10.2.2.
SECONDARY DATA SOURCES
10.3.
RESEARCH METHODOLOGY
10.3.1.
EVALUATION OF PROPOSED MARKET
10.3.2.
IDENTIFICATION OF DATA SOURCES
10.3.3.
ASSESSMENT OF MARKET DETERMINANTS
10.3.4.
DATA COLLECTION
10.3.5.
DATA VALIDATION & ANALYSIS
TABLE 1: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE
TYPE, 2019-2027 (IN $ MILLION)
TABLE 4: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
METHODOLOGY, 2019-2027 (IN $ MILLION)
TABLE 5: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
APPLICATIONS, 2019-2027 (IN $ MILLION)
TABLE 6: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
PRODUCTS & SERVICES, 2019-2027 (IN $ MILLION)
TABLE 7: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
END-USERS, 2019-2027 (IN $ MILLION)
TABLE 8: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING
MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
FIGURE 1: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
APPLICATIONS, 2018 & 2027 (IN %)
FIGURE 2: NORTH AMERICA OUTSOURCED INTRAOPERATIVE NEUROMONITORING
MARKET, 2019-2027 (IN $ MILLION)
FIGURE 3: NORTH AMERICA EP MARKET, 2019-2027 (IN $ MILLION)
FIGURE 4: NORTH AMERICA SPINAL SURGERY MARKET, 2019-2027 (IN $ MILLION)
FIGURE 5: NORTH AMERICA SERVICES MARKET, 2019-2027 (IN $ MILLION)
FIGURE 6: NORTH AMERICA AMBULATORY SURGICAL CENTERS MARKET, 2019-2027
(IN $ MILLION)
FIGURE 7: PORTER’S FIVE FORCE ANALYSIS
FIGURE 8: MARKET ATTRACTIVENESS INDEX
FIGURE 9: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
INSOURCED INTRAOPERATIVE NEUROMONITORING, 2019-2027 (IN $ MILLION)
FIGURE 10: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
OUTSOURCED INTRAOPERATIVE NEUROMONITORING, 2019-2027 (IN $ MILLION)
FIGURE 11: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY EEG
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 12: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY EMG
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 13: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY EP
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 14: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY SEP
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 15: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY TCMEP
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 16: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY BAEP
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 17: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY VEP
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 18: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY SPINAL
SURGERY, 2019-2027 (IN $ MILLION)
FIGURE 19: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY ENT
SURGERY, 2019-2027 (IN $ MILLION)
FIGURE 20: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
NEUROSURGERY, 2019-2027 (IN $ MILLION)
FIGURE 21: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
VASCULAR SURGERY, 2019-2027 (IN $ MILLION)
FIGURE 22: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
ORTHOPEDIC SURGERY, 2019-2027 (IN $ MILLION)
FIGURE 23: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY OTHER
SURGERIES, 2019-2027 (IN $ MILLION)
FIGURE 24: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 25: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
ACCESSORIES, 2019-2027 (IN $ MILLION)
FIGURE 26: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
SERVICES, 2019-2027 (IN $ MILLION)
FIGURE 27: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
HOSPITALS, 2019-2027 (IN $ MILLION)
FIGURE 28: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
AMBULATORY SURGICAL CENTERS (ASCs), 2019-2027 (IN $ MILLION)
FIGURE 29: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, REGIONAL
OUTLOOK, 2018 & 2027 (IN %)
FIGURE 30: UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET,
2019-2027 (IN $ MILLION)
FIGURE 31: CANADA INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027 (IN $
MILLION)